Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adrenocortical Carcinoma (ACC)”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Large-scale testing (Phase 3)Study completedNCT00924989
What this trial is testing

OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Astellas Pharma Inc 139
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Looking for participantsNCT06066333
What this trial is testing

Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

Who this might be right for
Adrenocortical CarcinomaACCMetastatic Adrenocortical Carcinoma
Memorial Sloan Kettering Cancer Center 12
Not applicableLooking for participantsNCT05237934
What this trial is testing

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

Who this might be right for
Neuroendocrine TumorsCarcinoma, Neuroendocrine
National Cancer Institute (NCI) 300
Testing effectiveness (Phase 2)Study completedNCT00454103
What this trial is testing

Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy

Who this might be right for
Adrenal TumorAdrenocortical Carcinoma
University of Wuerzburg
Early research (Phase 1)Looking for participantsNCT07189403
What this trial is testing

DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Advanced or Metastatic Adrenocortical CarcinomaMetastatic Castration-resistant Prostate Cancer
Daiichi Sankyo 40
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT00215202
What this trial is testing

Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)

Who this might be right for
Nonresectable Adrenocortical Carcinoma
Dartmouth-Hitchcock Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT00848016
What this trial is testing

Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery

Who this might be right for
Recurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma
National Cancer Institute (NCI) 29
Early research (Phase 1)Looking for participantsNCT06487481
What this trial is testing

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma (ACC)Recurrent Adrenocortical Carcinoma (ACC)Recurrent Abdominal Adrenocortical Carcinoma (ACC)+2 more
National Cancer Institute (NCI) 32
Not applicableActive Not RecruitingNCT04358107
What this trial is testing

Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

Who this might be right for
Adrenocortical Carcinoma
National Cancer Institute (NCI) 1,000
Testing effectiveness (Phase 2)Ended earlyNCT00778817
What this trial is testing

IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma
National Cancer Institute (NCI) 20
Not applicableStudy completedNCT05344027
What this trial is testing

The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
King's College Hospital NHS Trust 35
Testing effectiveness (Phase 2)WithdrawnNCT00469469
What this trial is testing

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Dartmouth-Hitchcock Medical Center
Not applicableEnded earlyNCT04447014
What this trial is testing

Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)

Who this might be right for
Adrenocortical CarcinomaAdrenocortical Cancer
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT05913427
What this trial is testing

Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)

Who this might be right for
Adrenocortical Carcinoma
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 80
Early research (Phase 1)Study completedNCT01898715
What this trial is testing

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

Who this might be right for
Adrenocortical CarcinomaAdrenal CancerACC
Millendo Therapeutics, Inc. 63
Testing effectiveness (Phase 2)Study completedNCT00071058
What this trial is testing

Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer

Who this might be right for
Adrenal Cortex Neoplasms
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT01262235
What this trial is testing

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

Who this might be right for
CancerNeuroendocrine TumorsNET+2 more
Arbutus Biopharma Corporation 68